Ethic Inc. Decreases Stake in Relx Plc (NYSE:RELX)

Ethic Inc. trimmed its position in Relx Plc (NYSE:RELX) by 0.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 198,022 shares of the technology company’s stock after selling 460 shares during the period. Ethic Inc.’s holdings in Relx were worth $8,994,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. Private Trust Co. NA grew its stake in Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company’s stock valued at $56,000 after purchasing an additional 199 shares during the last quarter. Sage Mountain Advisors LLC boosted its position in Relx by 5.1% in the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company’s stock valued at $240,000 after buying an additional 258 shares during the last quarter. DRW Securities LLC boosted its position in Relx by 5.9% in the fourth quarter. DRW Securities LLC now owns 4,652 shares of the technology company’s stock valued at $211,000 after buying an additional 259 shares during the last quarter. Kovitz Investment Group Partners LLC increased its holdings in Relx by 3.4% in the 4th quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company’s stock worth $371,000 after buying an additional 267 shares during the period. Finally, Marks Group Wealth Management Inc raised its position in Relx by 1.3% during the 4th quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company’s stock worth $1,190,000 after buying an additional 325 shares during the last quarter. 15.02% of the stock is owned by institutional investors and hedge funds.

Relx Stock Performance

Shares of NYSE RELX opened at $53.84 on Friday. Relx Plc has a 1 year low of $42.77 and a 1 year high of $55.21. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The company’s fifty day moving average price is $50.59 and its 200 day moving average price is $48.69. The company has a market capitalization of $99.65 billion, a PE ratio of 28.95, a price-to-earnings-growth ratio of 2.73 and a beta of 0.86.

Relx Increases Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be paid a dividend of $0.5586 per share. This is a positive change from Relx’s previous semi-annual dividend of $0.23. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. Relx’s dividend payout ratio is presently 59.68%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on RELX. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research note on Wednesday, April 16th. The Goldman Sachs Group initiated coverage on Relx in a research report on Wednesday, March 26th. They set a “buy” rating on the stock. Barclays raised Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. Finally, StockNews.com lowered Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy”.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.